Enigmatic exosomal connection in lung cancer drug resistance
Sambit K. Patra,
No information about this author
Rajeev Kumar Sahoo,
No information about this author
Stuti Biswal
No information about this author
et al.
Molecular Therapy — Nucleic Acids,
Journal Year:
2024,
Volume and Issue:
35(2), P. 102177 - 102177
Published: March 22, 2024
Lung
cancer
remains
a
significant
global
health
concern
with
limited
treatment
options
and
poor
prognosis,
particularly
in
advanced
stages.
Small
extracellular
vesicles
such
as
exosomes,
secreted
by
cells,
play
pivotal
role
mediating
drug
resistance
lung
cancer.
Exosomes
have
been
found
to
facilitate
intercellular
communication
transferring
various
biomolecules
between
cells
their
microenvironment.
Additionally,
exosomes
can
transport
signaling
molecules
promoting
cell
survival
proliferation
conferring
chemotherapy.
Moreover,
modulate
the
tumor
microenvironment
inducing
phenotypic
changes
hindering
response.
Understanding
of
is
crucial
for
developing
novel
therapeutic
strategies
biomarkers
overcome
limitations.
In
this
review,
we
summarize
current
knowledge
on
conventional
emerging
mechanisms
involvement
well
exosome-mediated
factors
cancer.Graphical
abstract
Language: Английский
An updated review on the development of a nanomaterial-based field-effect transistor-type biosensors to detect exosomes for cancer diagnosis
Jeongyun An,
No information about this author
Hyunjun Park,
No information about this author
Minyoung Ju
No information about this author
et al.
Talanta,
Journal Year:
2024,
Volume and Issue:
279, P. 126604 - 126604
Published: July 22, 2024
Language: Английский
Exosome transmit the ability of migration and invasion in heterogeneous ovarian cancer cells by regulating autophagy via targeting hsa-miR-328
Hengzi Sun,
No information about this author
Xiao Huo,
No information about this author
Xiaoning Bi
No information about this author
et al.
Gynecologic Oncology,
Journal Year:
2025,
Volume and Issue:
194, P. 60 - 70
Published: Feb. 18, 2025
Language: Английский
Extracellular vesicles as nature's nano carriers in cancer therapy: insights toward preclinical studies and clinical applications
Xiaotong Wu,
No information about this author
Yuhua Meng,
No information about this author
Zhimeng Yao
No information about this author
et al.
Pharmacological Research,
Journal Year:
2025,
Volume and Issue:
unknown, P. 107751 - 107751
Published: May 1, 2025
Extracellular
vesicles
(EVs),
which
are
secreted
by
various
cell
types,
hold
significant
potential
for
cancer
therapy.
However,
there
several
challenges
and
difficulties
that
limit
their
application
in
clinical
settings.
This
review,
integrates
the
work
of
our
team
recent
advancements
this
research
field,
discusses
EV-based
treatment
strategies
to
guide
application.
The
following
discussed:
1)
leveraging
inherent
properties
EVs
development
treatments;
2)
modifying
using
EV
engineering
methods
improve
drug
loading
delivery;
3)
targeting
key
molecules
tumor-derived
(TDE)
synthesis
inhibit
production;
4)
clearing
TDEs
from
tumor
microenvironment.
Additionally,
on
basis
into
vaccines
bispecific
antibodies,
review
elaborates
enhance
antitumor
immunity
via
modifications
can
ability
stability
progress
AI
technology
targeted
delivery
drugs.
Although
limited
enhancing
abilities,
provides
an
in-depth
discussion
prior
studies.
Finally,
summarizes
use
therapy
highlights
need
be
addressed.
Language: Английский
Exosome Transmit the Ability of Migration and Invasion in Heterogeneous Ovarian Cancer Cells by Regulating Autophagy Via Targeting hsa-miR-328
Hengzi Sun,
No information about this author
Xiao Huo,
No information about this author
Xiaoning Bi
No information about this author
et al.
Published: Jan. 1, 2024
Language: Английский
Comparison of Lung Tissue‐Derived Extracellular Vesicles Using Multiple Dissociation Methods for Profiling Protein Biomarkers
Yue Han,
No information about this author
Meng Ye,
No information about this author
Sheng Ye
No information about this author
et al.
Biotechnology Journal,
Journal Year:
2024,
Volume and Issue:
19(9)
Published: Sept. 1, 2024
ABSTRACT
Extracellular
vesicles
(EVs)
operate
as
chemical
messengers
that
facilitate
intercellular
communication.
Emerging
evidence
has
demonstrated
lung
tissue‐derived
EVs
play
pivotal
roles
in
pulmonary
physiological
processes
and
have
potential
biomarkers
therapeutics
for
diseases.
Multiple
methods
been
proposed
the
isolation
of
EVs.
However,
effects
different
tissue
pre‐treatments
on
EV
subsequent
disease
biomarker
discovery
not
yet
comprehensively
investigated.
In
this
study,
we
compared
physical
characteristics,
recovery
yields,
protein
compositions
isolated
from
tissues
using
three
based
dissociation
principles.
Methodologically,
beneficial
blood
perfusion
gentle
meshing
were
emphasized
their
impact
yield
purity.
These
results
demonstrate
enrich
distinct
subpopulations
exhibit
significant
differences
cargo
surface
properties.
disparities
directly
affect
diagnostic
detection
marker
proteins
related
to
diseases,
including
tumors,
asthma,
fibrosis.
Collectively,
these
findings
highlight
variations
characteristics
resulting
applied
approaches
offer
compelling
suggestions
guiding
researchers
selecting
a
suitable
method
downstream
functional
studies
clinical
applications.
Language: Английский